Ben Tre Pharmaceutical JSC (DBT) — Cash Flow Quality Index
Ben Tre Pharmaceutical JSC (DBT) has a Cash Flow Quality Index of -4.79x as of March 2020. Operating cash flow of ₫-22.11 Billion is below net income of ₫4.62 Billion, suggesting accrual-heavy earnings not yet converted to cash. Check Ben Tre Pharmaceutical JSC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ben Tre Pharmaceutical JSC Cash Flow Quality Index (2016–2019)
Historical Cash Flow Quality Index for Ben Tre Pharmaceutical JSC across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. See defensive interval ratio of Ben Tre Pharmaceutical JSC to measure how many days the company can operate on defensive assets alone.
Annual Cash Flow Quality Index for Ben Tre Pharmaceutical JSC (2016–2019)
Year-by-year earnings quality comparison for Ben Tre Pharmaceutical JSC. For live market cap and the full company financial profile, see DBT market cap overview.
| Year | Quality Index | Operating CF (VND) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | -3.46x | ₫-74.12 Billion | ₫21.40 Billion | ▼ -546.9% |
| 2018 | -0.54x | ₫-10.81 Billion | ₫20.19 Billion | ▼ -130.1% |
| 2017 | 1.78x | ₫51.07 Billion | ₫28.74 Billion | ▲ +28.6% |
| 2016 | 1.38x | ₫32.71 Billion | ₫23.66 Billion | — |